A 12 Week, Open Label, Phase I/IIa Study Using Apatone(®) for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy

Por Tareen, Basir, Summers, Jack L., Jamison, James M., Neal, Deborah R., McGuire, Karen, Gerson, Lowell, Diokno, Ananias
Publicado em 2008

Nucleolar Changes and Fibrillarin Redistribution Following Apatone Treatment of Human Bladder Carcinoma Cells

Por Jamison, James M., Gilloteaux, Jacques, Perlaky, Laszlo, Thiry, Marc, Smetana, Karel, Neal, Deborah, McGuire, Karen, Summers, Jack L.
Publicado em 2010